Revisiting HER2-negative breast cancer in the era of HER2-low and HER2-ultralow expression: Assessment of interobserver variability.

Huang X, Anderson S, Dal Zotto V, Harada S, Kahn AG, Zhou M, Zhang K, Okamoto K, Wei S.

Open source

DOI
10.1016/j.breast.2026.104896
Published
2026-08-18
Container
Breast
Publisher
Not recorded
Open access
no

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.breast.2026.104896,
  title = {Revisiting HER2-negative breast cancer in the era of HER2-low and HER2-ultralow expression: Assessment of interobserver variability.},
  author = {Huang X and  Anderson S and  Dal Zotto V and  Harada S and  Kahn AG and  Zhou M and  Zhang K and  Okamoto K and  Wei S.},
  year = {2026},
  journal = {Breast},
  doi = {10.1016/j.breast.2026.104896},
  url = {https://doi.org/10.1016/j.breast.2026.104896}
}

RIS

TY  - JOUR
TI  - Revisiting HER2-negative breast cancer in the era of HER2-low and HER2-ultralow expression: Assessment of interobserver variability.
AU  - Huang X
AU  -  Anderson S
AU  -  Dal Zotto V
AU  -  Harada S
AU  -  Kahn AG
AU  -  Zhou M
AU  -  Zhang K
AU  -  Okamoto K
AU  -  Wei S.
PY  - 2026
JO  - Breast
DO  - 10.1016/j.breast.2026.104896
UR  - https://doi.org/10.1016/j.breast.2026.104896
ER  -

APA

X, H., S, A., V, D. Z., S, H., AG, K., M, Z., K, Z., K, O., & S., W. (2026). Revisiting HER2-negative breast cancer in the era of HER2-low and HER2-ultralow expression: Assessment of interobserver variability.. Breast. https://doi.org/10.1016/j.breast.2026.104896

Source records